D. Crawford

Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer

Ana M. González-Angulo, Argun Akçakanat, S. Liu et al. · Annals of Oncology · 2014 · 103 citations · Full text

Breast Oncology, Medicine, Standard Neoadjuvant Chemotherapy +5

Adjuvant radiotherapy and chemotherapy in breast cancer

C S McArdle, D. Crawford, Evelyn H. Dykes et al. · British journal of surgery · 1986 · 99 citations

Surgical Oncology, Breast Oncology, Radiation Therapy +13

Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability

R E Leake, L Laing, Kenneth C. Calman et al. · British Journal of Cancer · 1981 · 80 citations · Full text

Breast Oncology, Endocrine-related Cancer, Medicine +9

Effect of cavity margin shavings to ensure completeness of excision on local recurrence rates following breast conserving surgery

Ludger Barthelmes, Aref Awa, D. Crawford · European Journal of Surgical Oncology · 2003 · 41 citations

Gross Anatomy, Minimally Invasive Procedure, Cavity Margin Shavings +8

Phase I dose-escalation study of the SRC and multi-kinase inhibitor BMS-354825 in patients (pts) with GIST and other solid tumors

T. R. J. Evans, J. A. Morgan, Annick D. Van den Abbeele et al. · Journal of Clinical Oncology · 2005 · 31 citations

Multi-kinase Inhibitor Bms-354825, Ekg Monitoring, Pathology +19